1.Clinical Observation on the Shengqing Jiangzhuo Acupuncture Method Combined with Western Medical Treatment in Treating Gouty Nephropathy with Damp-Heat Accumulation Syndrome
Longlin ZHANG ; Fengzhi TAN ; Min YU ; Yaoyu DU ; Ao LUO ; Yihao LIU
Journal of Guangzhou University of Traditional Chinese Medicine 2025;42(7):1706-1713
Objective To evaluate the clinical efficacy of Shengqing Jiangzhuo(lifting lucid yang and lowering turbid yin)Acupuncture Method,based on the"turbidity-clearness interaction"theory,combined with western medicine in treating gouty nephropathy(GN)patients with damp-heat accumulation syndrome.Methods A total of 117 patients diagnosed with GN from September 2023 to September 2024 at the First Affiliated Hospital of Guangzhou University of Chinese Medicine Chongqing Hospital were enrolled and randomly divided into three groups,with 39 cases in each group.The western medicine group received Febuxostat Tablets,the control group was given western medicine+conventional acupuncture,and observation group was given western medicine+Shengqing Jiangzhuo Acupuncture Method.All groups received 4 weeks of treatment.Clinical efficacy,traditional Chinese medicine(TCM)syndrome scores,visual analogue scale(VAS)of pain scores,and laboratory parameters—including serum uric acid(UA),blood urea nitrogen(BUN),creatinine(Scr),estimated glomerular filtration rate(eGFR),β2-microglobulin(β2-MG),24-hour urinary protein(24h-UTP),cystatin C(CysC)were assessed.The erythrocyte sedimentation rate(ESR),and C-reactive protein(CRP)were compared before and after treatment.Results(1)The total effective rate was 71.79%(28/39)in the western medicine group,84.62%(33/39)in the control group,and 92.31%(36/39)in the observation group.The observation group demonstrated statistically significant superiority over the western medicine group(P<0.05),while showing marginally better efficacy than the control group without statistical significance(P>0.05).(2)After treatment,all three groups exhibited significant improvements in ESR,CRP,and UA levels(P<0.05).The observation group significantly outperformed the other two groups in reducing ESR and CRP levels(P<0.05),and was statistically superior to the western medicine group in lowering UA levels(P<0.05),though no significant difference was observed versus the control group for UA improvement(P>0.05).The control group showed significantly greater reductions in ESR,CRP,and UA levels than the western medicine group(P<0.05).(3)After treatment,Scr,BUN,and eGFR levels were significantly improved in all groups(P<0.05).The observation group achieved significantly better improvements in Scr and eGFR than the other two groups(P<0.05).However,no statistical difference existed between the control and western medicine groups for Scr or eGFR enhancement(P>0.05).No intergroup differences were detected in BUN improvement(P>0.05).(4)Significant differences emerged in β2-MG and CysC levels among all groups after treatment(P<0.05).Both observation and control groups demonstrated statistically significant improvements in 24-hour 24h-UTP(P<0.05),whereas the western medicine group showed no significant change(P>0.05).The observation group significantly outperformed the other groups in reducing 24h-UTP and β2-MG levels(P<0.05),and was superior to the western medicine group in lowering CysC(P<0.05),though no difference versus the control group was observed for CysC reduction(P>0.05).The control group showed no statistical advantage over the western medicine group in improving 24h-UTP,β 2-MG,or CysC(P>0.05).(5)After treatment,TCM syndrome scores and VAS scores were significantly improved in all groups(P<0.05).The observation group achieved significantly greater reductions in TCM syndrome scores and VAS scores than the western medicine group(P<0.05).The control group showed statistically superior VAS score improvement versus the western medicine group(P<0.05),but no significant differences emerged in TCM syndrome score improvement compared to either group(P>0.05).No statistical difference existed between observation and control groups for VAS score reduction(P>0.05).Conclusion Shengqing Jiangzhuo Acupuncture Method,grounded in the"turbidity-clearness interaction"theory,effectively reduces serum UA,controls inflammation,and preserves renal function in damp-heat accumulation type of GN,demonstrating significant therapeutic benefits.
2.Protein expression, purification and mouse antiserum preparation of monkeypox virus A23R.
Yihao WANG ; Mingzhi LI ; Mengle JIA ; Lingdi YANG ; Jiaqi XIONG ; Ting WANG ; Yu WANG ; Shurong LIU ; Wenli GUO ; Lingbao KONG ; Meifeng LI
Chinese Journal of Cellular and Molecular Immunology 2023;39(7):642-648
Objective To express the monkeypox virus (MPXV) A23R protein in Escherichia coli and purify by Ni-NTA affinity column, and to prepare mouse antiserum against MPXV A23R. Methods The recombinant plasmid pET-28a-MPXV-A23R was constructed and transformed into Escherichia coli BL21 to induce the expression of A23R protein. After optimizing the conditions of expression, A23R protein was highly expressed. Recombinant A23R protein was purified by Ni-NTA affinity column and identified by Western blot analysis. The purified protein was used to immunize mice for preparing the A23R polyclonal antibody, and the antibody titer was detected by ELISA. Results The expression of A23R recombinant protein reached the peak under the induced conditions of 0.6 mmol/L isopropyl-β-D-thiogalactoside (IPTG), 37 DegreesCelsius and 20 hours. The purity of the protein was about 96.07% and was identified by Western blot analysis. The mice were immunized with recombinant protein, and the titer of antibody reached 1:102 400 at the 6th week after immunization. Conclusion MPXV A23R is expressed highly and purified with a high purity and its antiserum from mouse is obtained with a high titre.
Animals
;
Mice
;
Monkeypox virus
;
Antibodies
;
Enzyme-Linked Immunosorbent Assay
;
Blotting, Western
;
Recombinant Proteins
;
Escherichia coli/genetics*
3.Ketogenic diet in the treatment of polycystic ovary syndrome
Yihao GU ; Guofang CHEN ; Yu CHEN ; Chao LIU
Chinese Journal of Endocrinology and Metabolism 2023;39(9):813-816
The ketogenic diet, a non-pharmacotherapy, simulates the state of fasting to induce the liver to metabolize fatty acids into ketones as fuel source. It also possesses anti-inflammatory effects and impacts the occurrence and progression of various diseases among which is polycystic ovary syndrome(PCOS). Ketogenic diet effectively manages body weight, improves ovarian function, regulates metabolic disorder, and enhances mental health. The growing body of evidence substantiates the safety and efficacy profile.
4.Research advances in the prevention and treatment of hepatic ischemia-reperfusion injury with traditional Chinese medicine components
Zhen LI ; Yihao ZENG ; Ke WANG ; Kaiqiang WANG ; Kexian YU
Journal of Clinical Hepatology 2022;38(2):471-476
Hepatic ischemia-reperfusion injury (HIRI) is a very common complication of liver transplantation, liver resection, and shock. At present, many studies have been conducted on HIRI, but there is still a lack of drugs for radical treatment in clinical practice. Many factors, such as related cells, molecular mechanisms and signaling pathways, reactive oxygen species and oxidative stress response, nitric oxide, and mitochondria, mediate the development and progression of HIRI, which leads to the decline of patients' quality of life and even endangers their life safety. Based on the pathogenesis of HIRI and related articles, this article summarizes the research advances in the prevention and treatment of HIRI with traditional Chinese medicine components, so as to provide theoretical support for basic research and clinical research on HIRI.
5.Discovery of novel heteroaryl alkynes for highly potent KITD816V cells inhibition to treat gastrointestinal stromal tumors.
Zhicheng XIE ; Lin LI ; Yihao GUO ; Mi ZHANG ; Taiwen CHEN ; Yongpeng LI ; Xin LI ; Xi ZHU ; Yu ZHANG ; Liguang LOU ; Youhong HU
Acta Pharmaceutica Sinica B 2022;12(10):4004-4007
6.Clinical characteristics and prognosis of 49 newly diagnosed primary central nervous system diffuse large B-cell lymphoma
Jia SONG ; Hui LIU ; Hongli SHEN ; Lanzhu YUE ; Xuejun YANG ; Wenjing SONG ; Cuiyun SUN ; Shizhu YU ; Kai DING ; Yihao WANG ; Lijuan LI ; Hong YU ; Yuanyuan SHAO ; Chaomeng WANG ; Shuyuan YUE ; Rong FU
Chinese Journal of Hematology 2021;42(11):917-922
Objective:The clinical characteristics of patients with primary central nervous system lymphoma-diffuse large B-cell lymphoma (PCNSL-DLBCL) and the effects of different treatment schemes on their survival and prognosis were analyzed retrospectively.Methods:A total of 49 patients with PCNSL-DLBCL who presented at the Tianjin Medical University General Hospital from July 2014 to December 2020 were included, and their clinical data were retrospectively analyzed. They were divided into four groups: the MTX group, the R-CDOP group, the BTKi-R-MTX group, and the RLZT group. The median overall survival (OS) and progression-free survival (PFS) were calculated, and the survival prognosis was compared by univariate and multivariate prognostic analysis.Results:The median OS time of the MTX group, the R-CDOP group, the BTKi-R-MTX group, and the RLZT group was 16.5 months, 4.5 months, 42 months, and not reached, respectively ( P<0.001) . The median PFS time of the MTX group, the R-CDOP group, the BTKi-R-MTX group, and the RLZT group was 7 months, 1.5 months, 20 months, and 5 months, respectively ( P=0.005) . Multivariate prognostic analysis showed that double expressor lymphoma, IESLG risk grade, and different treatment methods were the prognostic factors of PCNSL-DLBCL. Conclusion:The survival and prognosis of PCNSL-DLBCL are affected by different treatment schemes. The role of CD20 monoclonal antibody in the treatment of PCNSL-DLBCL is still controversial. The treatment scheme containing BTKi has great potential for PCNSL-DLBCL. RLZT scheme has a good prospect for elderly patients who cannot tolerate high-dose chemotherapy and radiotherapy.
7. Study on related factors of depression in patients with chronic obstructive pulmonary disease
Chinese Journal of Primary Medicine and Pharmacy 2019;26(22):2744-2747
Objective:
To investigate the incidence rate and related factors of depression in patients with chronic obstructive pulmonary disease(COPD).
Methods:
From February 2016 to November 2016, 261 COPD patients in Wenzhou Central Hospital were collected by cluster sampling method.The patients' medical history, classification of lung function, score of Self-Rating Depression Scale(SDS) and COPD assessment test(CAT) were recorded in order to investigate the incidence rate and related factors of depression.
Results:
The incidence of depression in COPD patients was 42.53%.Spearman's correlation showed that the factors related to depression including without spouse, smoking, duration of COPD and classification of lung function(
8. Characteristic and function of peripheral blood mononuclear cells-induced macrophages in patients with myelodysplastic syndrome
Yu HAN ; Huaquan WANG ; Rong FU ; Wen QU ; Erbao RUAN ; Xiaoming WANG ; Guojin WANG ; Yuhong WU ; Hong LIU ; Jia SONG ; Jing GUAN ; Limin XING ; Lijuan LI ; Huijuan JIANG ; Hui LIU ; Yihao WANG ; Chunyan LIU ; Wei ZHANG ; Zonghong SHAO
Chinese Journal of Hematology 2017;38(8):706-709
Objective:
To explore characteristic and function of peripheral blood mononuclear cells (PBMNC) -induced macrophages in patients with myelodysplastic syndrome (MDS) to couple with its progression.
Methods:
A total of 24 MDS patients (11 low-risk patients and 13 high-risk group patients) referred to Department of Hematology of Tianjin Medical University General Hospital and normal controls were enrolled from September 2014 to December 2015. PBMNC was stimulated with GM-CSF to transform to macrophages. The morphology of macrophages was observed by microscope. The quantity of macrophages, CD206 and SIRPα on surface of macrophages were detected by flow cytometry. The phagocytic function of macrophages was analyzed by fluorescence microscopy and flow cytometry.
Results:
The morphology of macrophages from MDS patients was abnormal. The percentage of transformed macrophages was (5.17±3.47) % in patients with MDS, which was lower than that in controls significantly[ (66.18±13.43) %,
9.Efficiency comparison of two nebulization inhalation therapy methods
Chinese Journal of Practical Nursing 2009;25(8):36-37
Objective To observe the efficiency of two nebulization inhalation therapy methods in patients with non-invasive ventilation. Methods 60 patients with non-invasive ventilation were divided in-to two groups (30 cases in each group). Based on combination therapy, the observation group received oxy- gen drived nebulizer inhalation therapy through tube system of non - invasive ventilator, the control group re- ceived inhalation therapy by oxygen drived nebulizer directly with halt of non- invasive ventilation. The effi- ciency of two methods was compared between the two groups. Results At the end of treatment SaO2 in the observation group remained nearly unchanged, while that of the control group significantly de-creased,beart rate increased in both groups,bot the amplitude was lower in the observation group. Patients in the observation group showed no evident discomfort, alleviated gasp and eosy expectoration. Conclu-sions Inhalation therapy through tube system of non- invasive ventilator was more efficient and it is worthy of wide clinical application.

Result Analysis
Print
Save
E-mail